Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ Free cash flow

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$757M-55.3%
Pfizer logo
PfizerPFE
$2.18B+23.0%
Procter & Gamble logo
Procter & GamblePG
$3.03B+6.3%
Merck & Co. logo
Merck & Co.MRK
$2.93B+150%
Tenet Healthcare logo
Tenet HealthcareTHC
——

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%

Valuation

See full
Market cap$589.48B+63.6%
Enterprise value$622.78B+66.4%
P/E28×+11.5×
P/S6.1×+2.1×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Calculated from Johnson & Johnson’s reported figures.

$2.5Bnet cash from operating−$1.0Bcapital expenditures=$1.47B

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's free cash flow?
Johnson & Johnson (JNJ) reported free cash flow of $1.47B in Q1 2026.
How has Johnson & Johnson's free cash flow changed year-over-year?
Johnson & Johnson's free cash flow decreased by 56.6% year-over-year, from $3.38B to $1.47B.
What is the long-term trend for Johnson & Johnson's free cash flow?
Over 4 years (2021 to 2025), Johnson & Johnson's free cash flow has grown at a -0.1% compound annual growth rate (CAGR), from $19.76B to $19.7B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.